v-src induces cisplatin resistance by in
β
Naoko Masumoto; Shuji Nakano; Hiromitsu Fujishima; Kimitoshi Kohno; Yoshiyuki Ni
π
Article
π
1999
π
John Wiley and Sons
π
French
β 133 KB
π 1 views
Activation of Src, which has an intrinsic protein tyrosine kinase (PTK) activity, has been demonstrated in human solid tumors, such as colorectal and breast cancers. To investigate the role of activated Src in drug resistance, we evaluated the effect of v-src on the resistance to various anti-cancer